How Microchem assists clients in the product authorization process for micronized products.

In the intricate journey toward regulatory approval of pharmaceutical products, deficiency letters stand as a hurdle that can slow down or jeopardize the acquisition of necessary authorizations. Microchem distinguishes itself with its capability to guide its clients through a proper navigation of regulatory requests.

The Challenge of Deficiency Letters

When clients receive deficiency letters from regulatory authorities, they face specific requests for additional clarifications or documentary integrations regarding micronized products. These letters might range from demands for more details on the process and quality controls to inquiries about analytical procedures and the frequencies of analyses.

Microchem's Response Process

Microchem adopts a proactive and collaborative approach in responding to deficiency letters, enriching existing documentation with detailed and specific information. This includes the submission of procedure excerpts that clearly outline operational controls, particle size, and the frequency of particle size analyses. Our expertise and knowledge enable us to interpret the authority's requests and provide useful responses to meet their needs.

Clarification and Integration Strategy

When further clarifications are requested by the authorities, Microchem steps in with detailed explanations. The aim is to resolve any ambiguities left after the initial presentation and supplement the documentation with additional data or procedures that adequately address regulatory concerns.

Towards a Future of Compliance and Success

Microchem's expertise in handling deficiency letters underscores our strong commitment to supporting clients through the challenges of the complex regulatory process, ensuring their micronized products are market-ready in compliance with all applicable regulations.

Facing similar obstacles or in need of specialized regulatory assistance? Contact us to discover how we can help you reaching the goal of approval.

Contact Us

Start a project with us

Find out how Munit can help you to increase the bioavailability of your pharmaceutical substances by reducing their particle size.

Cookie bar

We use cookies and other tracking technologies to improve your experience and analyse our website traffic.

Please consult our Privacy Policy for more information.

By clicking on “Accept”, you consent to your data being collected

You can change your cookie settings and disable cookies, except for essential functional ones, at any time.